StonvexLoading…
StonvexStonvexStonvexCore line items from CCS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.12B | $4.40B | $3.69B | $4.51B |
Operating Income | $194.41M | $440.06M | $350.83M | $676.90M |
Net Income | $147.60M | $333.82M | $259.22M | $525.13M |
EPS (Diluted) | $4.86 | $10.40 | $8.05 | $15.92 |
Total Assets | $4.46B | $4.53B | $4.14B | $3.77B |
Total Liabilities | $1.87B | $1.91B | $1.75B | $1.62B |
Cash & Equivalents | $109.44M | $150.00M | $226.15M | $296.72M |
Free Cash Flow OCF − CapEx | $124.31M | $86.72M | $-1.69M | $294.94M |
Shares Outstanding | 29.05M | 30.96M | 31.77M | 31.77M |